Janus RX LLC

Based in the US, Janus RX LLC specializes in providing tailored pharmacy services focused on mental health and behavioral care, ensuring a comprehensive continuum of care for diverse health communities. Janus RX LLC, founded in 2016, operates as a provider of pharmacy services specifically designed for mental health and behavioral health communities. The company is headquartered in Montgomery, US. The founder's prior history is not available.

Janus RX LLC has engaged in 1 deal with the most recent deal occurring on October 23, 2025, with FFL Partners investing in the company, though financial terms were not disclosed. Janus Pharmacy specializes in long-term care solutions tailored for mental and behavioral health communities. The company’s core offerings encompass a comprehensive range of pharmacy services designed to ensure a seamless continuum of care. This includes services such as compliance packaging, customized delivery solutions, telepharmacy, and support in prescription dispensing and billing.

Janus Pharmacy serves a diverse client base that includes healthcare facilities, inpatient services, and outpatient programs across multiple states, including Alabama, Florida, and Texas. By focusing on integrity, compassion, excellence, and innovation, Janus Pharmacy aims to address the unique needs of its end users—individuals who require specialized pharmaceutical care throughout various stages of their treatment. Janus Pharmacy generates revenue through a structured transaction model that includes partnerships with healthcare providers and facilities, as well as direct service offerings to end-users. The company’s business transactions typically involve providing tailored pharmacy services and medication management solutions, ensuring that clients receive consistent and high-quality support.

Revenue streams may include service fees for compliance packaging and delivery, as well as billing related to inpatient filling and discharge prescriptions. Flagship services, such as the injection clinic and telepharmacy, represent key components of the company’s revenue structure. These offerings ensure Janus Pharmacy remains a vital resource within the healthcare ecosystem, facilitating effective medication management and adherence for patients in need. Janus RX LLC plans to leverage recent funding to expand its market reach.

This includes the development of new products aimed at enhancing pharmacy services tailored for mental and behavioral health, with potential launches anticipated post-2025. The company also aims to penetrate additional geographic markets to broaden its client base, although specific regions have not yet been disclosed.